Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SILO
SILO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SILO News
Federal Initiatives Propel Innovation in Mental Health Treatments
Apr 29 2026
Newsfilter
Silo Pharma Expands into AI Technology Business
Apr 23 2026
NASDAQ.COM
Silo Pharma Advances Psychedelic Therapies for Mental Health
Apr 20 2026
NASDAQ.COM
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
stocktwits
SPC-15 PTSD Program Aligns with Federal Push for Mental Health Therapies
Apr 20 2026
Newsfilter
Silo Pharma Secures Patent for PTSD Therapy
Apr 07 2026
stocktwits
Silo Pharma Secures European Patent for Stress Disorder Prevention
Apr 07 2026
NASDAQ.COM
Silo Pharma Secures EPO Patent Approval for 5-HT4 Therapy
Apr 06 2026
Newsfilter
SILO PHARMA GRANTED EUROPEAN PATENT FOR INNOVATIVE PTSD PREVENTION TREATMENT
Apr 06 2026
moomoo
Silo Pharma Authorizes $1 Million Share Repurchase Program
Feb 24 2026
NASDAQ.COM
Keysight Technologies Quarterly Earnings Beat Estimates
Feb 24 2026
Benzinga
Silo Pharma Approves $1M Share Buyback Program
Feb 23 2026
seekingalpha
SILO PHARMA SECURES NOTICE OF ALLOWANCE IN JAPAN FOR SPC-15, ENHANCING GLOBAL INTELLECTUAL PROPERTY ASSETS
Feb 18 2026
moomoo
Silo Pharma Partners with Allucent to Advance SPC-15 Clinical Studies
Dec 30 2025
Globenewswire
Silo Pharma Enters LOI with Allucent for SPC-15 Clinical Studies
Dec 30 2025
Newsfilter
Silo Pharma Collaborates with Allucent to Assist in Upcoming FDA Investigational New Drug Application for SPC-15 as a PTSD Treatment
Nov 17 2025
Newsfilter
Show More News
